UK researchers released first ever national strategy for cancer vaccine development, focusing on pre-cancer biology & tumor-specific proteins to create preventive vaccines. They highlight mRNA tech’s potential for personalized treatments, aligning with GSK & Oxford’s £50M cancer vaccine initiative

4 hours ago 3
submitted by /u/QuantaHealth
[link] [comments]
Read Entire Article